The global human microbiome therapeutic market is expected to grow at a CAGR of around 42.1% during 2023-2030. This report on global human microbiome therapeutic market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global human microbiome therapeutic market by segmenting the market based on technology, therapeutic area, type, and region. Also, detailed profiles of companies operating in the human microbiome therapeutic market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
- Human Microbiome as a Validated Target for Drug Development
- Increasing Focus on Human Microbiome Therapeutics Development
- Increasing Collaboration Between Public-Private Organizations
Market Challenges
- Stringent Government Regulations
- Lack of Expertise and Adequate Research
Historical & Forecast Period
- Base Year: 2022
- Historical Period: 2018-2022
- Forecast Period: 2023-2030
Market by Technology
- Genomics
- Proteomics
- Metabolomics
Market by Route of Therapeutic Area
- Neurological Disorders
- Dermatological Indications
- Cancers
- Metabolic Disorders
- Gastrointestinal Disorders
- Others
Market by Type
- Probiotics and Prebiotics
- Medical Food
- Diagnostic Tests
- Others
Market by Region
- Europe
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions about the Human Microbiome Therapeutics Market
What is the estimated value of the Human Microbiome Therapeutics Market?
What is the growth rate of the Human Microbiome Therapeutics Market?
What is the forecasted size of the Human Microbiome Therapeutics Market?
Who are the key companies in the Human Microbiome Therapeutics Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 127 |
| Published | April 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 293.49 Million |
| Forecasted Market Value ( USD | $ 3433.4 Million |
| Compound Annual Growth Rate | 42.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
Table of Contents
1. Preface1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Human Microbiome Therapeutic Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Human Microbiome Therapeutic Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Human Microbiome Therapeutic Market by Technology
5.1. Introduction
5.2. Geonomics
5.3. Proteomics
5.4. Metabolomics
6. Global Human Microbiome Therapeutic Market by Therapeutic Area
6.1 Introduction
6.2 Neurological Disorders
6.3 Dermatological Indications
6.4 Cancers
6.5 Metabolic Disorders
6.6 Gastrointestinal Disorders
6.7 Others
7. Global Human Microbiome Therapeutic Market by Type
7.1 Introduction
7.2 Prebiotics and Probiotics
7.3 Medical Food
7.4 Diagnostic Tests
7.5 Others
8. Global Human Microbiome Therapeutic Market by Region
8.1 Introduction
8.2 Europe
8.3 North America
8.4 Asia Pacific
8.5 Latin America
8.6 Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1 Competitive Scenario
12.2 Company Profiles
12.2.1 Bristol-Myers Squibb
12.2.2 Dow Inc Chemical
12.2.3 Takeda Pharmaceutical Company Limited
12.2.4 Johnson & Johnson
12.2.5 DuPont de Nemours, Inc.
12.2.6 Merck & Co. Inc.
12.2.7 Pfizer Inc.
12.2.8 Vertex Pharmaceuticals
12.2.9 Evelo Biosciences, Inc.
12.2.10 Kaleido Biosciences, Inc.
12.2.11 Seres Therapeutics, Inc.
12.2.12 PureTech Health PLC
List of Figures
Figure 1: Global Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 2: Global Human Microbiome Therapeutic Market by Technology, 2022
Figure 3: Global Human Microbiome Therapeutic Market by Therapeutic Area, 2022
Figure 4: Global Human Microbiome Therapeutic Market by Type, 2022
Figure 5: Global Human Microbiome Therapeutic Market by Region, 2022
Figure 6: Global Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 7: Global Human Microbiome Therapeutic Market by Technology (in %), 2022 & 2030
Figure 8: Global Genomics Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 9: Global Genomics Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 10: Global Proteomics Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 11: Global Proteomics Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 12: Global Metabolomics Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 13: Global Metabolomics Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 14: Global Human Microbiome Therapeutic Market by Therapeutic Area (in %), 2022 & 2030
Figure 15: Global Neurological Disorders Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 16: Global Neurological Disorders Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 17: Global Dermatological Indications Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 18: Global Dermatological Indications Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 19: Global Cancers Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 20: Global Cancers Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 21: Global Metabolic Disorders Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 22: Global Metabolic Disorders Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 23: Global Gastrointestinal Disorders Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 24: Global Gastrointestinal Disorders Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 25: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 26: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 27: Global Human Microbiome Therapeutic Market by Type (in %), 2022 & 2030
Figure 28: Global Probiotics and Prebiotics Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 29: Global Probiotics and Prebiotics Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 30: Global Medical Food Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 31: Global Medical Food Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 32: Global Diagnostics Test Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 33: Global Diagnostics Test Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 34: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 35: Global Other Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 36: Global Human Microbiome Therapeutic Market by Region (in %), 2022 & 2030
Figure 37: Europe Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 38: Europe Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 39: North America Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 40: North America Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 41: Asia Pacific Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 42: Asia Pacific Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 43: Latin America Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 44: Latin America Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 45: Middle East & Africa Human Microbiome Therapeutic Market (in US$ Million), 2018-2022
Figure 46: Middle East & Africa Human Microbiome Therapeutic Market (in US$ Million), 2023-2030
Figure 47: Market Value Chain
List of Tables
Table 1: Global Human Microbiome Therapeutic Market Portraiture
Table 2: Global Human Microbiome Therapeutic Market by Technology (in US$ Million), 2022 & 2030
Table 3: Global Human Microbiome Therapeutic Market by Therapeutic Area (in US$ Million), 2022 & 2030
Table 4: Global Human Microbiome Therapeutic Market by Type (in US$ Million), 2022 & 2030
Table 5: Global Human Microbiome Therapeutic Market by Region (in US$ Million), 2022 & 2030
Table 6: List of Key Players
Companies Mentioned
- Bristol-Myers Squibb
- Dow Inc Chemical
- Takeda Pharmaceutical Company Limited
- Johnson & Johnson
- DuPont de Nemours, Inc.
- Merck & Co. Inc.
- Pfizer Inc.
- Vertex Pharmaceuticals
- Evelo Biosciences, Inc.
- Kaleido Biosciences, Inc.
- Seres Therapeutics, Inc.
- PureTech Health PLC
Methodology
LOADING...
